SCHEMBL1963535

SCHEMBL1963535

CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCCN)OCCCCC(=O)OC

nearest known ligand 0.64

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 2/20 0.64
LPAR1 Q92633 4/20 0.57
LPAR3 Q9UBY5 4/20 0.57
LPAR2 Q9HBW0 1/20 0.51
TLR2 O60603 2/20 0.51
P2RY10 O00398 4/20 0.47
GPR34 Q9UPC5 2/20 0.47
FABP3 P05413 1/20 0.47
PLA2G2D Q9UNK4 1/20 0.46
ENPP2 Q13822 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2231646 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL2236272 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL13352076 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL2235295 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL2235444 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL12348817 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL12345663 1.00 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL2234690 0.98 PLA2G2C (0.64) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL2231204 0.97 PLA2G2C (0.58) PLA2G2CLPAR1LPAR3LPAR2TLR2
SCHEMBL10141359 0.90 PLA2G2C (0.63) PLA2G2CLPAR1LPAR3LPAR2TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2348866-A1 OXIDIZED LIPID COMPOUNDS AND USES THEREOF Vascular Biogenics Ltd. (IL) 2011-08-03 EP disclosed
WO-2010052718-A9 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2011-06-16 WO disclosed
WO-2010052718-A1 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2010-05-14 WO disclosed